Enrolling by invitationPhase 3NCT06908473

Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Intervention
Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment.(drug)
Enrollment
530 enrolled
Eligibility
65 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

TCM hospital of Sichuan Province · Xiyuan Hospital of CACMS · Shanxi Provincial hospital of Chinese Medicine · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine · Yinchuan Brain-Heart Simultaneous Treatment Internet Hospital Co., Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06908473 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome →

← Back to all trials